Actinium Pharmaceuticals, Inc. (ATNM)

NYSEAMERICAN: ATNM · IEX Real-Time Price · USD

7.11

-0.11 (-1.52%)

At close: Jul 19, 2024, 4:00 PM

7.20

+0.09 (1.27%)

Pre-market: Jul 22, 2024, 8:17 AM EDT

Actinium Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Net Income	-46.45	-48.82	-33.02	-24.77	-22.22	-21.9	Upgrade
Depreciation & Amortization	0.82	0.79	0.7	0.52	0.45	0.42	Upgrade
Share-Based Compensation	4.23	3.84	2.8	1.69	1.25	1.3	Upgrade
Other Operating Activities	1.77	-3.15	38.17	1.69	-1.1	-1.28	Upgrade
Operating Cash Flow	-39.63	-47.34	8.64	-20.87	-21.62	-21.46	Upgrade
Capital Expenditures	-0.09	-0.15	-0.37	-0.13	-0.25	-0.06	Upgrade
Investing Cash Flow	-0.09	-0.15	-0.37	-0.13	-0.25	-0.06	Upgrade
Share Issuance / Repurchase	28.87	14.87	23.16	35.31	76.64	17.44	Upgrade
Debt Issued / Paid	-0.01	-0	-0.05	-0.09	-0.46	-0.32	Upgrade
Financing Cash Flow	28.87	14.87	23.11	35.22	76.18	17.11	Upgrade
Net Cash Flow	-10.85	-32.62	31.39	14.22	54.31	-4.41	Upgrade
Free Cash Flow	-39.72	-47.49	8.28	-21	-21.87	-21.53	Upgrade
Free Cash Flow Margin	-49037.04%	-58627.16%	803.69%	-1835.58%	-	-	Upgrade
Free Cash Flow Per Share	-1.42	-1.78	0.34	-1.02	-1.80	-4.33	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).